| pubmed-article:16829721 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16829721 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:16829721 | lifeskim:mentions | umls-concept:C0002932 | lld:lifeskim |
| pubmed-article:16829721 | lifeskim:mentions | umls-concept:C0373746 | lld:lifeskim |
| pubmed-article:16829721 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:16829721 | lifeskim:mentions | umls-concept:C1963547 | lld:lifeskim |
| pubmed-article:16829721 | lifeskim:mentions | umls-concept:C0580836 | lld:lifeskim |
| pubmed-article:16829721 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16829721 | pubmed:dateCreated | 2006-7-10 | lld:pubmed |
| pubmed-article:16829721 | pubmed:abstractText | Pharmacological interventions may play a prominent role in reducing organ damage in response to physiologic stress. A growing body of evidence indicates that volatile anesthetics exert protective effects against ischemia-reperfusion injury in vivo. Administration of volatile anesthetics before prolonged coronary artery occlusion and reperfusion has been shown to produce cardioprotection, a phenomenon termed anesthetic-induced preconditioning. Endogenous signal transduction proteins, reactive oxygen species, mitochondria, and ion channels have been implicated in anesthetic-induced preconditioning, and new data regarding the triggering and effector roles for these various components have been discovered that advance our understanding of the mechanisms responsible for anesthetic-induced preconditioning. This review will update and integrate these recent data into the current mechanistic model of anesthetic-induced preconditioning. | lld:pubmed |
| pubmed-article:16829721 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16829721 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16829721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16829721 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16829721 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16829721 | pubmed:issn | 0952-7907 | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:WangChenC | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:PagelPaul SPS | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:WarltierDavid... | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:KerstenJudy... | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:WeihrauchDoro... | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:Bienengraeber... | lld:pubmed |
| pubmed-article:16829721 | pubmed:author | pubmed-author:PrattPhillip... | lld:pubmed |
| pubmed-article:16829721 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16829721 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:16829721 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16829721 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16829721 | pubmed:pagination | 397-403 | lld:pubmed |
| pubmed-article:16829721 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:meshHeading | pubmed-meshheading:16829721... | lld:pubmed |
| pubmed-article:16829721 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16829721 | pubmed:articleTitle | Cardioprotection by volatile anesthetics: new applications for old drugs? | lld:pubmed |
| pubmed-article:16829721 | pubmed:affiliation | Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA. | lld:pubmed |
| pubmed-article:16829721 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16829721 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:16829721 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16829721 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16829721 | lld:pubmed |
